Catalent plans to invest an estimated $45 million to expand its facilities and purchase new equipment for its production ...

Catalent Pharma Solutions' latest expansion in Madison is bringing a boost to Wisconsin’s growing biohealth sector, with a ...

Catalent will invest $45 million to expand in Madison, supporting the state’s growth as a federal biohealth tech hub.

Novo Holdings' $16.5bn takeover of US CDMO Catalent has been completed, after months of debate over potential antitrust issues.

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

Novo Nordisk is buying three Catalent facilities for $11bn in a bid to resolve supply issues holding back growth of Ozempic for diabetes and obesity therapy Wegovy.

NJBIZ spotlights under-recognized health care leaders, from startup founders to behind-the-scenes pros driving innovation.

ROME (Reuters) -Italian authorities on Monday appointed a special commissioner to help Danish drugmaker Novo Nordisk speedily ...

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team Egham, UK – 03 ...

The budget committee voted 13-3 with Sen. LaTonya Johnson (D-Milwaukee) joining Republicans in favor of approving the ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.

The global geriatric care services market, valued at $1 trillion in 2022, is projected to more than double by 2033, driven by ...